SEC Form 4 · Updated Daily
PLX
— PROTALIX BIOTHERAPEUTICS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| Sheratzki Eyal | 10%+ Owner · Director | 14,466,319 | 2006-12-31 | A |
| Camber Capital Management LLC | 10%+ Owner | 10,775,000 | 2016-12-02 | S |
| FROST PHILLIP MD ET AL | 10%+ Owner | 7,764,810 | 2009-09-09 | S |
| Frost Gamma Investments Trust | 10%+ Owner | 7,764,810 | 2009-09-09 | S |
| Toussia-Cohen Sharon | 10%+ Owner · Director | 6,556,381 | 2006-12-31 | A |
| Marathon Investments Ltd. | 10%+ Owner | 6,556,381 | 2006-12-31 | A |
| Techno-Rov Holdings (1993) Ltd | 10%+ Owner | 6,186,046 | 2006-12-31 | A |
| Akirov Alfred | Director | 4,927,713 | 2013-08-14 | S |
| Hurvitz Eli | Director | 4,898,982 | 2009-11-12 | M |
| Oren Dan | 10%+ Owner | 4,494,820 | 2021-06-02 | S |
| Dexcel Pharma Technologies Ltd. | 10%+ Owner | 4,494,820 | 2021-06-02 | S |
| Bronfeld Zeev | Director | 2,162,481 | 2014-10-02 | J |
| Bio-Cell Ltd | 10%+ Owner | 1,509,948 | 2014-09-16 | J |
| HSIAO JANE PH D | Director · Officer | 1,134,060 | 2007-01-31 | X |
| Rubin Eyal | Officer | 660,909 | 2024-09-23 | A |
| Shaaltiel Yoseph | Officer | 585,916 | 2016-09-15 | M |
| Aviezer David | Director · Officer | 418,000 | 2012-07-16 | A |
| Naos Yaron | Officer | 225,817 | 2025-09-03 | A |
| Bashan Dror | Director · Officer | 188,516 | 2025-12-19 | P |
| Almon Einat Brill | Officer | 185,000 | 2012-07-16 | A |
| Palash Tzvi | Officer | 102,000 | 2012-07-16 | A |
| Manor Moshe | Director · Officer | 50,000 | 2017-05-16 | P |
| Hayon Yael | Officer | 35,115 | 2023-08-15 | A |
| Lauterbach Sandra Leigh | Officer | 20,000 | 2012-07-16 | A |
| Maimon Yossi | Officer | 10,000 | 2015-12-14 | P |
| Ben Zvi Shmuel | Director | 7,500 | 2025-09-03 | A |
| Boudes Pol F | Director | 7,500 | 2025-09-03 | A |
| Elze Christian | Director | 7,500 | 2025-09-03 | A |
| Melincoff Gwen A | Director | 7,500 | 2025-09-03 | A |
| Forster Eliot | Director | 7,500 | 2025-09-03 | A |
| Schwartz Aharon | Director | 7,500 | 2025-09-03 | A |
| Mamlok Gilad | Director | 3,631 | 2025-08-24 | — |
| Bar-Shalev Amos | Director | 0 | 2025-11-18 | S |
| Lockshin Curtis | Director | 0 | 2006-07-05 | — |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-09-03 | Schwartz Aharon | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Schwartz Aharon | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Forster Eliot | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Forster Eliot | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Bashan Dror | Grant / award (derivative) | 160,000 | $0.00 | 160,000 |
| 2026-09-03 | Bashan Dror | Grant / award (derivative) | 320,000 | $0.00 | 320,000 |
| 2026-09-03 | Boudes Pol F | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Boudes Pol F | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Melincoff Gwen A | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Melincoff Gwen A | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Elze Christian | Grant / award (derivative) | 8,500 | $0.00 | 8,500 |
| 2026-09-03 | Elze Christian | Grant / award (derivative) | 17,000 | $0.00 | 17,000 |
| 2026-09-03 | Naos Yaron | Grant / award (derivative) | 56,000 | $0.00 | 56,000 |
| 2026-09-03 | Naos Yaron | Grant / award (derivative) | 112,000 | $0.00 | 112,000 |
| 2025-12-19 | Bashan Dror | Open-market buy | 56,000 | $1.81 | 188,516 |
| 2025-11-18 | Bar-Shalev Amos | Open-market sale | 168 | $1.87 | 0 |
| 2025-09-03 | Bashan Dror | Grant / award (derivative) | 340,000 | $0.00 | 340,000 |
| 2025-09-03 | Bashan Dror | Grant / award | 195,000 | — | 2,344,418 |
| 2025-09-03 | Naos Yaron | Grant / award (derivative) | 50,000 | $0.00 | 50,000 |
| 2025-09-03 | Naos Yaron | Grant / award | 25,000 | — | 225,817 |
| 2025-09-03 | Bar-Shalev Amos | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Bar-Shalev Amos | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Ben Zvi Shmuel | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Ben Zvi Shmuel | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Schwartz Aharon | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Schwartz Aharon | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Elze Christian | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Elze Christian | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Boudes Pol F | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Boudes Pol F | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Melincoff Gwen A | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Melincoff Gwen A | Grant / award | 7,500 | — | 7,500 |
| 2025-09-03 | Forster Eliot | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-09-03 | Forster Eliot | Grant / award | 7,500 | — | 7,500 |
| 2025-08-24 | Mamlok Gilad | — | — | — | 3,631 |
| 2025-06-10 | Schwartz Aharon | Open-market buy | 129,000 | $1.60 | 303,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.